Stereotaxis notification with the FDA for Vdrive Robotic system Stereotaxis announced that it has submitted a 510 Premarket Notification with the FDA for the Company's Vdrive Robotic Navigation System with V-Loop Variable Loop Catheter Manipulator. This submission includes both the single arm system and the two arm system. If cleared by the FDA, the Vdrive with V-Loop system will be the Company's second Vdrive product to be cleared for use in the U.S. Its Vdrive with V-Sono Intracardiac Echocardiography Catheter Manipulator received FDA clearance in July 2013 and has been utilized in more than 75 cardiac ablation procedures to date in North America.
Stereotaxis and Philips sign addendum to their agreement Stereotaxis announced Stereotaxis and Philips have signed an addendum pursuant to their existing Development and Cooperation Agreement to facilitate development of a new interface between each company's most advanced systems for electrophysiology and interventional cardiology procedures. The new interface will enable interoperability of Stereotaxis' Niobe ES remote magnetic navigation system with the latest version of Philips' cardiovascular X-ray system, Allura Xper FD10. This new interface is expected to be available in major global markets in 2016.